Annual SG&A
$5.66 M
-$2.24 M-28.31%
31 March 2024
Summary:
Portage Biotech annual selling, general & administrative expenses is currently $5.66 million, with the most recent change of -$2.24 million (-28.31%) on 31 March 2024. During the last 3 years, it has risen by +$536.00 thousand (+10.45%). PRTG annual SG&A is now -35.78% below its all-time high of $8.82 million, reached on 31 March 2022.PRTG Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.53 M
+$186.00 K+13.80%
30 June 2024
Summary:
Portage Biotech quarterly selling, general & administrative expenses is currently $1.53 million, with the most recent change of +$186.00 thousand (+13.80%) on 30 June 2024. Over the past year, it has dropped by -$159.00 thousand (-9.39%). PRTG quarterly SG&A is now -59.41% below its all-time high of $3.78 million, reached on 31 March 2021.PRTG Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$861.05 M
-$75.44 M-9.60%
30 June 2024
Summary:
Portage Biotech TTM selling, general & administrative expenses is currently -$861.05 million, with the most recent change of -$75.44 million (-9.60%) on 30 June 2024. Over the past year, it has dropped by -$867.72 million (-13018.99%). PRTG TTM SG&A is now -1208.58% below its all-time high of $10.07 million, reached on 31 December 2021.PRTG TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTG Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.3% | -9.4% | -10000.0% |
| 3 y3 years | +10.4% | -23.3% | -10000.0% |
| 5 y5 years | +560.9% | +262.6% | -10000.0% |
PRTG Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -35.8% | +10.4% | -39.4% | +22.3% | -473.5% | at low |
| 5 y | 5 years | -35.8% | +560.9% | -59.4% | +427.1% | -1128.2% | at low |
| alltime | all time | -35.8% | >+9999.0% | -59.4% | +2940.7% | -1208.6% | at low |
Portage Biotech Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $1.53 M(+13.8%) | $5.83 M(+2.9%) |
| Mar 2024 | $5.66 M(-28.3%) | $1.35 M(+7.5%) | $5.67 M(-0.5%) |
| Dec 2023 | - | $1.25 M(-25.9%) | $5.70 M(-14.6%) |
| Sept 2023 | - | $1.69 M(+23.6%) | $6.67 M(-5.6%) |
| June 2023 | - | $1.37 M(-0.6%) | $7.06 M(-10.6%) |
| Mar 2023 | $7.90 M(-10.4%) | $1.38 M(-38.0%) | $7.90 M(-12.7%) |
| Dec 2022 | - | $2.22 M(+6.5%) | $9.05 M(-0.2%) |
| Sept 2022 | - | $2.09 M(-5.6%) | $9.07 M(+1.0%) |
| June 2022 | - | $2.21 M(-12.6%) | $8.98 M(+1.9%) |
| Mar 2022 | $8.82 M(+72.0%) | $2.53 M(+12.9%) | $8.82 M(-12.4%) |
| Dec 2021 | - | $2.24 M(+12.0%) | $10.07 M(+21.6%) |
| Sept 2021 | - | $2.00 M(-2.3%) | $8.28 M(+24.4%) |
| June 2021 | - | $2.05 M(-45.8%) | $6.65 M(+29.8%) |
| Mar 2021 | $5.13 M(+174.2%) | $3.78 M(+736.1%) | $5.13 M(+163.8%) |
| Dec 2020 | - | $452.00 K(+20.2%) | $1.94 M(+9.0%) |
| Sept 2020 | - | $376.00 K(-27.8%) | $1.78 M(-2.6%) |
| June 2020 | - | $521.00 K(-12.4%) | $1.83 M(-2.1%) |
| Mar 2020 | $1.87 M(+118.2%) | $595.00 K(+104.5%) | $1.87 M(+4.4%) |
| Dec 2019 | - | $291.00 K(-31.2%) | $1.79 M(+8.4%) |
| Sept 2019 | - | $423.00 K(-24.6%) | $1.65 M(+24.8%) |
| June 2019 | - | $561.00 K(+8.5%) | $1.32 M(+54.5%) |
| Mar 2019 | $857.00 K(-40.8%) | $517.00 K(+240.1%) | $857.00 K(-36.0%) |
| Dec 2018 | - | $152.00 K(+61.7%) | $1.34 M(-1.6%) |
| Sept 2018 | - | $94.00 K(0.0%) | $1.36 M(-2.0%) |
| June 2018 | - | $94.00 K(-90.6%) | $1.39 M(-3.9%) |
| Mar 2018 | $1.45 M(-43.4%) | $1.00 M(+474.7%) | $1.45 M(+2.2%) |
| Dec 2017 | - | $174.00 K(+42.6%) | $1.42 M(+3.3%) |
| Sept 2017 | - | $122.00 K(-19.2%) | $1.37 M(-4.7%) |
| June 2017 | - | $151.00 K(-84.4%) | $1.44 M(-43.7%) |
| Mar 2017 | $2.56 M(-43.4%) | $969.00 K(+651.2%) | $2.56 M(+17.0%) |
| Dec 2016 | - | $129.00 K(-31.7%) | $2.19 M(-60.6%) |
| Sept 2016 | - | $189.00 K(-85.1%) | $5.54 M(-0.5%) |
| June 2016 | - | $1.27 M(+112.3%) | $5.57 M(+23.3%) |
| Mar 2016 | $4.51 M(+248.2%) | $597.80 K(-82.9%) | $4.51 M(-3.0%) |
| Dec 2015 | - | $3.49 M(+1526.9%) | $4.66 M(+253.3%) |
| Sept 2015 | - | $214.30 K(-1.0%) | $1.32 M(+2.4%) |
| June 2015 | - | $216.40 K(-70.7%) | $1.29 M(-0.8%) |
| Mar 2015 | $1.30 M(-13.4%) | $738.70 K(+398.1%) | $1.30 M(-21.4%) |
| Dec 2014 | - | $148.30 K(-18.9%) | $1.65 M(-1.2%) |
| Sept 2014 | - | $182.90 K(-19.4%) | $1.67 M(+1.9%) |
| June 2014 | - | $226.80 K(-79.2%) | $1.64 M(+9.4%) |
| Mar 2014 | $1.50 M(-3.9%) | $1.09 M(+546.4%) | $1.50 M(+57.3%) |
| Dec 2013 | - | $168.90 K(+11.4%) | $952.30 K(-2.6%) |
| Sept 2013 | - | $151.60 K(+76.5%) | $978.00 K(-65.7%) |
| June 2013 | - | $85.90 K(-84.3%) | $2.85 M(-7.2%) |
| Mar 2013 | $1.56 M(-2.6%) | $545.90 K(+180.5%) | $3.07 M(+7.9%) |
| Dec 2012 | - | $194.60 K(-90.4%) | $2.85 M(-4.4%) |
| Sept 2012 | - | $2.03 M(+559.9%) | $2.98 M(+113.7%) |
| June 2012 | - | $307.10 K(-3.9%) | $1.39 M(-14.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | $1.60 M(-35.7%) | $319.70 K(-2.3%) | $1.62 M(+30.0%) |
| Dec 2011 | - | $327.10 K(-25.7%) | $1.25 M(-38.1%) |
| Sept 2011 | - | $440.50 K(-17.4%) | $2.02 M(-16.4%) |
| June 2011 | - | $533.40 K(-1087.8%) | $2.41 M(-0.8%) |
| Mar 2011 | $2.49 M(-2.9%) | -$54.00 K(-104.9%) | $2.43 M(-41.6%) |
| Dec 2010 | - | $1.10 M(+30.9%) | $4.16 M(+16.1%) |
| Sept 2010 | - | $837.00 K(+51.5%) | $3.58 M(+22.2%) |
| June 2010 | - | $552.50 K(-67.1%) | $2.93 M(+15.5%) |
| Mar 2010 | $2.56 M(+305.8%) | $1.68 M(+223.6%) | $2.54 M(+149.9%) |
| Dec 2009 | - | $518.10 K(+179.0%) | $1.02 M(+50.3%) |
| Sept 2009 | - | $185.70 K(+16.9%) | $676.00 K(+4.0%) |
| June 2009 | - | $158.80 K(+3.5%) | $650.00 K(-4.9%) |
| Mar 2009 | $631.00 K(-13.4%) | $153.40 K(-13.9%) | $683.80 K(-5.2%) |
| Dec 2008 | - | $178.10 K(+11.5%) | $721.60 K(+0.6%) |
| Sept 2008 | - | $159.70 K(-17.1%) | $717.00 K(-1.7%) |
| June 2008 | - | $192.60 K(+0.7%) | $729.70 K(+2.5%) |
| Mar 2008 | $728.70 K(+8.0%) | $191.20 K(+10.2%) | $712.00 K(+1.2%) |
| Dec 2007 | - | $173.50 K(+0.6%) | $703.60 K(+2.0%) |
| Sept 2007 | - | $172.40 K(-1.4%) | $690.10 K(+0.8%) |
| June 2007 | - | $174.90 K(-4.3%) | $684.90 K(-1.0%) |
| Mar 2007 | $674.50 K(-69.3%) | $182.80 K(+14.2%) | $692.00 K(-1.0%) |
| Dec 2006 | - | $160.00 K(-4.3%) | $699.10 K(-17.1%) |
| Sept 2006 | - | $167.20 K(-8.1%) | $843.00 K(-31.1%) |
| June 2006 | - | $182.00 K(-4.2%) | $1.22 M(-42.8%) |
| Mar 2006 | $2.20 M(-49.5%) | $189.90 K(-37.5%) | $2.14 M(-61.9%) |
| Dec 2005 | - | $303.90 K(-44.5%) | $5.62 M(+1.4%) |
| Sept 2005 | - | $547.40 K(-50.2%) | $5.54 M(+6.0%) |
| June 2005 | - | $1.10 M(-70.0%) | $5.23 M(+18.9%) |
| Mar 2005 | $4.36 M(+307.1%) | $3.67 M(+1502.4%) | $4.40 M(+173.4%) |
| Dec 2004 | - | $228.80 K(-2.1%) | $1.61 M(+11.3%) |
| Sept 2004 | - | $233.80 K(-12.9%) | $1.45 M(+11.3%) |
| June 2004 | - | $268.50 K(-69.4%) | $1.30 M(+21.9%) |
| Mar 2004 | $1.07 M(+371.8%) | $877.40 K(+1241.6%) | $1.07 M(+355.1%) |
| Dec 2003 | - | $65.40 K(-25.2%) | $234.20 K(-7.3%) |
| Sept 2003 | - | $87.40 K(+145.5%) | $252.70 K(+15.8%) |
| June 2003 | - | $35.60 K(-22.3%) | $218.20 K(-5.9%) |
| Mar 2003 | $227.00 K(-67.0%) | $45.80 K(-45.4%) | $231.90 K(-46.4%) |
| Dec 2002 | - | $83.90 K(+58.6%) | $432.90 K(-34.8%) |
| Sept 2002 | - | $52.90 K(+7.3%) | $664.30 K(-2.3%) |
| June 2002 | - | $49.30 K(-80.0%) | $679.70 K(-2.2%) |
| Mar 2002 | $688.10 K(+64.5%) | $246.80 K(-21.7%) | $694.90 K(+44.2%) |
| Dec 2001 | - | $315.30 K(+361.6%) | $481.90 K(+87.1%) |
| Sept 2001 | - | $68.30 K(+5.9%) | $257.50 K(+36.1%) |
| June 2001 | - | $64.50 K(+90.8%) | $189.20 K(+51.7%) |
| Mar 2001 | $418.20 K(+4000.0%) | $33.80 K(-62.8%) | $124.70 K(+37.2%) |
| Dec 2000 | - | $90.90 K | $90.90 K |
| Mar 2000 | $10.20 K(-19.0%) | - | - |
| Mar 1999 | $12.60 K(-72.5%) | - | - |
| Mar 1998 | $45.90 K | - | - |
FAQ
- What is Portage Biotech annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Portage Biotech?
- What is Portage Biotech annual SG&A year-on-year change?
- What is Portage Biotech quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Portage Biotech?
- What is Portage Biotech quarterly SG&A year-on-year change?
- What is Portage Biotech TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Portage Biotech?
- What is Portage Biotech TTM SG&A year-on-year change?
What is Portage Biotech annual selling, general & administrative expenses?
The current annual SG&A of PRTG is $5.66 M
What is the all time high annual SG&A for Portage Biotech?
Portage Biotech all-time high annual selling, general & administrative expenses is $8.82 M
What is Portage Biotech annual SG&A year-on-year change?
Over the past year, PRTG annual selling, general & administrative expenses has changed by -$2.24 M (-28.31%)
What is Portage Biotech quarterly selling, general & administrative expenses?
The current quarterly SG&A of PRTG is $1.53 M
What is the all time high quarterly SG&A for Portage Biotech?
Portage Biotech all-time high quarterly selling, general & administrative expenses is $3.78 M
What is Portage Biotech quarterly SG&A year-on-year change?
Over the past year, PRTG quarterly selling, general & administrative expenses has changed by -$159.00 K (-9.39%)
What is Portage Biotech TTM selling, general & administrative expenses?
The current TTM SG&A of PRTG is -$861.05 M
What is the all time high TTM SG&A for Portage Biotech?
Portage Biotech all-time high TTM selling, general & administrative expenses is $10.07 M
What is Portage Biotech TTM SG&A year-on-year change?
Over the past year, PRTG TTM selling, general & administrative expenses has changed by -$867.72 M (-13018.99%)